Human breast cancer tumor models: molecular imaging of drug susceptibility and dosing during HER2/neu-targeted therapy.

MLA

Gee MS, et al. “Human Breast Cancer Tumor Models: Molecular Imaging of Drug Susceptibility and Dosing during HER2/Neu-Targeted Therapy.” Radiology, vol. 248, no. 3, Sept. 2008, pp. 925–35. EBSCOhost, https://doi.org/10.1148/radiol.2482071496.

APA

Gee MS, Upadhyay R, Bergquist H, Alencar H, Reynolds F, Maricevich M, Weissleder R, Josephson L, Mahmood U, Gee, M. S., Upadhyay, R., Bergquist, H., Alencar, H., Reynolds, F., Maricevich, M., Weissleder, R., Josephson, L., & Mahmood, U. (2008). Human breast cancer tumor models: molecular imaging of drug susceptibility and dosing during HER2/neu-targeted therapy. Radiology, 248(3), 925–935. https://doi.org/10.1148/radiol.2482071496

Chicago

Gee MS, Upadhyay R, Bergquist H, Alencar H, Reynolds F, Maricevich M, Weissleder R, et al. 2008. “Human Breast Cancer Tumor Models: Molecular Imaging of Drug Susceptibility and Dosing during HER2/Neu-Targeted Therapy.” Radiology 248 (3): 925–35. doi:10.1148/radiol.2482071496.